Life-threatening pseudophaeochromocytoma after toloxatone, terbutaline, and phenylephrine.
Lefebvre
H
H
Richard
R
R
Noblet
C
C
Moore
N
N
Wolf
L M
LM
D000310:Adrenal Gland Neoplasms / Q000175:diagnosis*; D000368:Aged; D002395:Catecholamines / Q000378:metabolism; D003937:Diagnosis, Differential; D004347:Drug Interactions; D005260:Female; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects*; D010080:Oxazoles / Q000009:adverse effects*; D023303:Oxazolidinones; D010656:Phenylephrine / Q000009:adverse effects*; D010673:Pheochromocytoma / Q000175:diagnosis*; D013726:Terbutaline / Q000009:adverse effects*; D014661:Vasoconstriction / Q000187:drug effects
D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D010080:Oxazoles; D023303:Oxazolidinones; D010656:Phenylephrine; C010798:toloxatone; D013726:Terbutaline